November 2020

GAITHERSBURG, Md.--(BUSINESS WIRE)--Neuraly, Inc., a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders,…

Super User 0

Love0

News

November 2, 2020

Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

Three Emmes employees were among the co-authors of the recent report, "Safety and Immunogenicity of…

Super User 0

Love0

Cancer is Curable Know Earlier Take Action Together Thrive Detect

News

November 2, 2020

JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

MADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection…

Super User 0

Love0

News

November 2, 2020

REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology…

Super User 0

Love0

News

November 2, 2020

Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

Over the past nine months, more than $7 billion in federal money has poured into…

Super User 0

Love0

New Johns Hopkins Center Will Research COVID 19 Immunity CBS Baltimore

News

November 2, 2020

New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

ANNAPOLIS (WJZ) — A NIH initiative will fund a new Johns Hopkins center to research…

Super User 0

Love0

News

November 2, 2020

Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

Greater Baltimore is one of few regions ideally suited to pioneer the future of digital…

Super User 0

Love0

What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal

Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)

Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire

Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

About BioHealth Innovation

Contact

Connect